The Orlando Women's Center is your safe haven for an efficient, non-surgical method of terminating pregnancies, called the Abortion Pill Procedure.
But what is this procedure exactly?
Imagine it as a two-step process, using two FDA-approved medications, Mifepristone and Misoprostol . It's like a one-day outpatient procedure that doesn't involve any surgical intervention.
Now, who can opt for this procedure? The One Hour Abortion Pill Procedure is open to anyone who is between 3 to 24 weeks pregnant. It's like running a race – the earlier you start, the higher your chances of winning. In fact, those between 3 to 14 weeks of pregnancy might even bag a significant discount if they tick certain boxes.
So, how does this process work? Picture Mifepristone as a key that shuts off the body's supply of progesterone, causing the pregnancy to separate from the uterine wall and the uterus to contract, like a balloon deflating. Misoprostol then steps in, like a trigger, initiating further uterine contractions to expel the pregnancy tissue.
The success rate of this procedure is impressive. It's like hitting a home run 94 to 99 times out of 100 when used for pregnancies between 3 to 10 weeks. This method is not new; it's been widely used in Europe with a complication rate as low as 1% or less. It's like choosing a safe shortcut instead of a risky, long route which is surgical abortion .
However, it's not for everyone. Certain health conditions, like adrenal failure, liver disease, blood clotting abnormalities, and undiagnosed pelvic infections, may be roadblocks to this procedure. It's crucial to discuss with your healthcare provider to know if this is the right path for you.
Why should you consider the Abortion Pill Procedure? It's a non-surgical method, has a higher success rate in early stages of pregnancy, comes with minimal complications, and is a viable alternative to surgical abortion. Plus, it's readily available at the Orlando Women's Center.
To learn more or to book an appointment, just head on over to the Orlando Women's Center website.
